Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Enting

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
BMJ Open|September 28, 2019
Graham Roberts Study protocol: first 'trials within cohort study' for bladder cancerHarriet Wylie, Fidelma Cahill, Aida Santaolalla, et al.
European Urology|February 5, 2019
Consensus in Bladder Cancer Research Priorities Between Patients and Healthcare Professionals Using a Four-stage Modified Delphi MethodAgustina Bessa, Steven Maclennan, Deborah Enting, et al.
BJU International|July 1, 2025
Artificial intelligence-driven streamlining of prostate cancer multidisciplinary team recommendations in a tertiary NHS centre in the UKAhmed Khattak, Danny Ruta, Vivek Patkar, et al.
BMC Cancer|September 26, 2020
Cohort profile: King's Health Partners bladder cancer biobankPinky Kotecha, Charlotte L Moss, Deborah Enting, et al.
Plos One|January 28, 2021
The need for supportive mental wellbeing interventions in bladder cancer patients: A systematic review of the literatureAgustina Bessa, Elke Rammant, Deborah Enting, et al.
BMC Urology|June 5, 2020
Unmet needs in sexual health in bladder cancer patients: a systematic review of the evidenceAgustina Bessa, Rebecca Martin, Christel Häggström, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2021
Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE)Simon J Crabb, Sarah Danson, James W F Catto, et al.
Nature Medicine|August 7, 2025
Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the randomized phase 3 CheckMate 274 trialMatthew D Galsky, Dean F Bajorin, Yoshihiko Tomita, et al.
Frontiers in Oncology|January 24, 2024
A cohort profile of the Graham Roberts study cohortBeth Russell, Poppy Leech, Harriet Wylie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2022
A Randomized, Double-Blind, Biomarker-Selected, Phase II Clinical Trial of Maintenance Poly ADP-Ribose Polymerase Inhibition With Rucaparib Following Chemotherapy for Metastatic Urothelial CarcinomaSimon J Crabb, Syed Hussain, Eileen Soulis, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
BMJ Open|September 28, 2019
Graham Roberts Study protocol: first 'trials within cohort study' for bladder cancerHarriet Wylie, Fidelma Cahill, Aida Santaolalla, et al.
European Urology|February 5, 2019
Consensus in Bladder Cancer Research Priorities Between Patients and Healthcare Professionals Using a Four-stage Modified Delphi MethodAgustina Bessa, Steven Maclennan, Deborah Enting, et al.
BJU International|July 1, 2025
Artificial intelligence-driven streamlining of prostate cancer multidisciplinary team recommendations in a tertiary NHS centre in the UKAhmed Khattak, Danny Ruta, Vivek Patkar, et al.
BMC Cancer|September 26, 2020
Cohort profile: King's Health Partners bladder cancer biobankPinky Kotecha, Charlotte L Moss, Deborah Enting, et al.
Plos One|January 28, 2021
The need for supportive mental wellbeing interventions in bladder cancer patients: A systematic review of the literatureAgustina Bessa, Elke Rammant, Deborah Enting, et al.
BMC Urology|June 5, 2020
Unmet needs in sexual health in bladder cancer patients: a systematic review of the evidenceAgustina Bessa, Rebecca Martin, Christel Häggström, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2021
Phase I Trial of DNA Methyltransferase Inhibitor Guadecitabine Combined with Cisplatin and Gemcitabine for Solid Malignancies Including Urothelial Carcinoma (SPIRE)Simon J Crabb, Sarah Danson, James W F Catto, et al.
Nature Medicine|August 7, 2025
Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the randomized phase 3 CheckMate 274 trialMatthew D Galsky, Dean F Bajorin, Yoshihiko Tomita, et al.
Frontiers in Oncology|January 24, 2024
A cohort profile of the Graham Roberts study cohortBeth Russell, Poppy Leech, Harriet Wylie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2022
A Randomized, Double-Blind, Biomarker-Selected, Phase II Clinical Trial of Maintenance Poly ADP-Ribose Polymerase Inhibition With Rucaparib Following Chemotherapy for Metastatic Urothelial CarcinomaSimon J Crabb, Syed Hussain, Eileen Soulis, et al.
Pageof 5